MedTrace Logo

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

NCT02759198 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2019-01-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.

Conditions

Interventions

DRUG

YH23537

Drug: YH23537 750mg Drug: YH23537 1500mg Drug: YH23537 3000mg

DRUG

Celecoxib

Drug: Celecoxib 200mg

DRUG

YH23537 placebo

Drug: YH23537 750mg placebo Drug: YH23537 1500mg placebo Drug: YH23537 3000mg placebo

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Yoon Je Cho, M.D, Ph.D · Kyunghee University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-02
Primary Completion
2017-05-24
Completion
2017-09-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02759198 on ClinicalTrials.gov